Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.

Autor: Haikala HM; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 360 Longwood Ave, 02215, Boston, MA, USA., Anttila JM; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Marques E; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Raatikainen T; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Ilander M; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland., Hakanen H; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland., Ala-Hongisto H; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Savelius M; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Balboa D; Research Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland., Von Eyss B; Leibniz Institute of Age Research, Fritz Lipmann Institute e.V, Beutenbergstraße 11, 07745, Jena, Germany., Eskelinen V; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Munne P; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland., Nieminen AI; Department of Biosciences and Institute of Biotechnology, University of Helsinki, Viikinkaari 5, 00790, Helsinki, Finland., Otonkoski T; Research Programs Unit/Molecular Neurology, Biomedicum Stem Cell Center, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland., Schüler J; Oncotest GmbH, (Now part of Charles River Laboratories Inc, 251 Ballardvale St, Wilmington, MA 01887, USA), Freiburg, Germany., Laajala TD; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.; Department of Mathematics and Statistics, University of Turku, Vesilinnantie 5, 20500, Turku, Finland., Aittokallio T; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 3, 00290, Helsinki, Finland.; Department of Mathematics and Statistics, University of Turku, Vesilinnantie 5, 20500, Turku, Finland., Sihto H; Research Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland., Mattson J; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland., Heikkilä P; Department of Pathology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 3, 00290, Helsinki, Finland., Leidenius M; Breast Surgery Unit, Helsinki University Hospital, Kasarmikatu 11-13, 00290, Helsinki, Finland., Joensuu H; Research Programs Unit / Translational Cancer Biology & Medicum, University of Helsinki, P.O. Box 63, (Street address: Haartmaninkatu 8), 00290, Helsinki, Finland.; Department of Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland., Mustjoki S; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland., Kovanen P; Department of Pathology, HUSLAB and Haartman Institute, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 3, 00290, Helsinki, Finland., Eilers M; Theodor Boveri Institute and Comprehensive Cancer Center Mainfranken, Biocenter, University of Würzburg, Am Hubland, D-970074, Germany., Leverson JD; Oncology Development, AbbVie, Inc., 1 N Waukegan Road, North Chicago, 60064, IL, USA., Klefström J; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology and Medicum, University of Helsinki, Street address: Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki, Finland. Juha.Klefstrom@helsinki.fi.

Publikováno v: Nature communications [Nat Commun] 2019 Feb 20; Vol. 10 (1), pp. 932. Date of Electronic Publication: 2019 Feb 20.